1. The business mainly operates in the United States, with its core business focused on the R&D, production, and sales of infant formula.
2. It is an emerging brand in the health / medical / infant food industry, facing regulatory scrutiny, with competitors including Enfamil and Similac.
3. The brand terms used on the official website are "ByHeart" or "ByHeart Formula".